Medical Condition News

RSS

Inspiration, Ipsen receive FDA Fast Track designation for OBI-1 to treat AHA

Ipsen and Inspiration Biopharmaceuticals Inc. today announced that Inspiration has received Fast Track designation from the US Food and Drug Administration (FDA) for OBI-1 in acquired hemophilia A.

20 Nov 2012

Researchers discover new gene for susceptibility to Alzheimer's disease

A large-scale international study involving French researchers from the Inserm-Institut Pasteur Lille-Universit- Lille Nord de France "Public health and molecular epidemiology of ageing-related diseases" joint research unit led by Philippe Amouyel, has just discovered a gene for susceptibility to a rare disease that causes susceptibility to a common one, Alzheimer's disease, providing evidence of the heterogeneous aetiology of Alzheimer's disease.

20 Nov 2012

$Digital X-ray radiogrammetry can help identify patients with increased risk of hip fracture$

Digital X-ray radiogrammetry can help identify patients with increased risk of hip fracture

A new study from Karolinska Institutet in Sweden shows, that a technique for measuring bone density called digital X-ray radiogrammetry (or DXR) used on standard hand radiographs can help to identify patients with a higher risk of hip fracture.

20 Nov 2012

Finnish researchers develop triumphant solution to predict breast cancer cells’ responses to drugs

The answer is yes. Finnish researchers have developed a triumphant solution for predicting responses of breast cancer cells to a set of cancer drugs. The prediction is based on the genomic profiles of the cancer cells. Harnessing genomic profiles of cells in choosing the best treatment is considered the holy grail of personalised medicine.

20 Nov 2012

No link between lunar phases and incidence of psychological problems: Study

Contrary to popular belief, there is no connection between lunar phases and the incidence of psychological problems. This is the conclusion reached by a team of researchers directed by Professor Genevi-ve Belleville of Universit- Laval's School of Psychology after having examined the relationship between the moon's phases and the number of patients who show up at hospital emergency rooms experiencing psychological problems.

20 Nov 2012

Top-line results from Pfizer's pregabalin CR formulation Phase 3 study on fibromyalgia

Pfizer Inc. announced that top-line results of a double-blind, Phase 3 study evaluating pregabalin controlled-release (CR) formulation in patients with fibromyalgia indicate that pregabalin CR had a statistically significant positive effect compared to placebo in the primary endpoint, time to loss of therapeutic response (LTR).

20 Nov 2012

TBI, age-related dementia and stroke fuel neurologic disability in India

The 'Global Perspectives' published in the Nov. 20, 2012 issue of Neurology-, the medical journal of the American Academy of Neurology, features "Neurologic Disability: A Hidden Epidemic for India".

20 Nov 2012

KLF4 genetic factor prevents blood vessels from blockages

Researchers at Case Western Reserve University School of Medicine have identified a genetic factor that prevents blockages from forming in blood vessels, a discovery that could lead to new therapies for cardiovascular diseases.

20 Nov 2012

Smoking less a valid risk reduction strategy, says researcher

Countless studies demonstrate the virtues of complete smoking cessation, including a lowered risk of disease, increased life expectancy, and an improved quality of life. But health professionals acknowledge that quitting altogether can be a long and difficult road, and only a small percentage succeed.

20 Nov 2012

St. Jude Medical’s Portico transcatheter heart valve receives European CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced it has received European CE Mark approval for its 23 mm Portico Transcatheter Aortic Heart Valve and Transfemoral Delivery System.

20 Nov 2012

Combination of perifosine and temsirolimus shows promise against malignant glioma

Aeterna Zentaris Inc. today announced that perifosine, its oral AKT inhibitor, combined with temsirolimus ("TEM"), was well tolerated in an investigator driven Phase 1 clinical trial in recurrent or progressive malignant glioma ("MG").

20 Nov 2012

International Association of Eating Disorders Professionals symposium to be held in Nevada

The International Association of Eating Disorders Professionals (iaedp) announces its 2013 Symposium slated for March 21-24 at the Westin Lake Las Vegas Resort and Spa in Henderson, Nevada. The program is celebrating its 27th year with five keynote speakers as headliners addressing innovative approaches to eating disorder treatment as well as thirty-two workshop presenters and preconference training sessions.

20 Nov 2012

Ventus Medical introduces Provent Sleep Apnea Therapy in Canada

Ventus Medical is pleased to announce the introduction of its proprietary Provent Sleep Apnea Therapy into Canada. Provent Therapy is an innovative, non-invasive treatment for obstructive sleep apnea (OSA).

20 Nov 2012

CFFT announces major expansion of research collaboration with Pfizer

Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, today announced a major expansion of its research collaboration with Pfizer Inc. designed to discover new drugs to treat people with the most common mutation of CF, Delta F508.

20 Nov 2012

Dune Medical Devices gets FDA PMA Approvable Letter for MarginProbe System

Dune Medical Devices, Inc., announced today that it has received an Approvable Letter for its Premarket Approval Application (PMA) from the Food and Drug Administration. The Approvable Letter states that the MarginProbe System PMA is approvable subject to final agreement with FDA on the design of the required Post Approval Study.

20 Nov 2012

Diffusion Pharmaceuticals completes trans sodium crocetinate Phase I trial on glioblastoma

Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium crocetinate (TSC) in nine patients with newly diagnosed primary brain cancer (glioblastoma or GBM).

19 Nov 2012

GSK receives FDA approval for PROMACTA to treat thrombocytopenia

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.

19 Nov 2012

New fiber-optic device can deliver light to the brain in 3D

A new tool for neuroscientists delivers a thousand pinpricks of light to a chunk of gray matter smaller than a sugar cube. The new fiber-optic device, created by biologists and engineers at the Massachusetts Institute of Technology (MIT) in Cambridge, is the first tool that can deliver precise points of light to a 3-D section of living brain tissue. The work is a step forward for a relatively new but promising technique that uses gene therapy to turn individual brain cells on and off with light.

19 Nov 2012

KemPharm announces successful Type B meeting with FDA for KP201

KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today a successful Type B meeting with the Food and Drug Administration (FDA) for its lead pain candidate, KP201.

19 Nov 2012

Overexpression of BCL6 results in transformation of neural stem cells into cortical neurons

The cerebral cortex is the most complex structure in our brain and the seat of consciousness, emotion, motor control and language. In order to fulfill these functions, it is composed of a diverse array of nerve cells, called cortical neurons, which are affected by many neurological and neuropsychiatric diseases.

19 Nov 2012

Medical Condition News

Inspiration, Ipsen receive FDA Fast Track designation for OBI-1 to treat AHA

Researchers discover new gene for susceptibility to Alzheimer's disease

Digital X-ray radiogrammetry can help identify patients with increased risk of hip fracture

Finnish researchers develop triumphant solution to predict breast cancer cells’ responses to drugs

No link between lunar phases and incidence of psychological problems: Study

Top-line results from Pfizer's pregabalin CR formulation Phase 3 study on fibromyalgia

TBI, age-related dementia and stroke fuel neurologic disability in India

KLF4 genetic factor prevents blood vessels from blockages

Smoking less a valid risk reduction strategy, says researcher

St. Jude Medical’s Portico transcatheter heart valve receives European CE Mark approval

Combination of perifosine and temsirolimus shows promise against malignant glioma

International Association of Eating Disorders Professionals symposium to be held in Nevada

Ventus Medical introduces Provent Sleep Apnea Therapy in Canada

CFFT announces major expansion of research collaboration with Pfizer

Dune Medical Devices gets FDA PMA Approvable Letter for MarginProbe System

Diffusion Pharmaceuticals completes trans sodium crocetinate Phase I trial on glioblastoma

GSK receives FDA approval for PROMACTA to treat thrombocytopenia

New fiber-optic device can deliver light to the brain in 3D

KemPharm announces successful Type B meeting with FDA for KP201

Overexpression of BCL6 results in transformation of neural stem cells into cortical neurons

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News